← Back to Intel
Insider ActivityRXRX
Gibson Christopher, Director at RECURSION PHARMACEUTICALS, INC., sold $130K of RXRX
Updated Jun 17, 2026
Gibson Christopher
Director
RECURSION PHARMACEUTICALS, INC. ·
$RXRX
Transaction Details
| Insider | Gibson Christopher |
|---|---|
| Title | Director |
| Company | RECURSION PHARMACEUTICALS, INC. |
| Ticker | RXRX |
| Transaction Type | Sale |
| Transaction Date | 2026-03-23 |
| Shares Traded | 40,000 |
| Price Per Share | $3.25 |
| Total Value | $130K |
| Filed Date | 2026-03-25 |
| Accession Number | 0001601830-26-000052 |
Ownership Context
| Shares Owned After Transaction | 906,556 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001601830-26-000052
Other Insider Trades — RXRX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Khan Najat | CEO and President, Director | sold | $84K | 2026-06-05 |
| Gibson Christopher | Director | traded | — | 2026-06-05 |
| Gibson Christopher | Director | sold | $145K | 2026-06-05 |
| Bumpus Namandje | Director | sold | $16K | 2026-06-03 |
| Borgeson Blake | Director | sold | $110K | 2026-06-02 |
| Gibson Christopher | Director | traded | — | 2026-05-22 |
| Gibson Christopher | Director | sold | $123K | 2026-05-22 |
| Gibson Christopher | Director | traded | $69K | 2026-05-15 |
| Hallett David | Chief Scientific Officer | traded | $81K | 2026-05-15 |
| Khan Najat | CEO and President, Director | traded | $191K | 2026-05-15 |
Other Trades by Gibson Christopher
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | sold | $145K | 2026-06-05 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | — | 2026-06-05 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | traded | — | 2026-06-03 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | sold | $123K | 2026-05-22 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | — | 2026-05-22 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | $69K | 2026-05-15 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | sold | $135K | 2026-05-07 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | — | 2026-05-07 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | — | 2026-05-07 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | traded | — | 2026-04-22 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RXRX — RECURSION PHARMACEUTICALS, INC. →
Whisper Score — RXRX
48.8
Active Discussion
Current Whisper Score
Track RXRX insider activity in real time on The Wire →
Get alerts when Gibson Christopher files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 17, 2026 at 07:21 UTC